A comprehensive view of Epidemic / Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published: April 15, 2024 by FiercePharma
Global ocean freight rates have been falling since 2022 following pandemic; experts warn that factors, such as expected increase in oil, fuels used for ocean shipping and problems in Panama Canal, could lead to increases in freight rates in coming months
Published: April 15, 2024 by CE Noticias Financieras
Podcast: Meaningful innovation in the CPG industry has ground nearly to a halt post-pandemic for all but an 'elite 20%' of companies, according to the Boston Consulting Group’s latest Build for the Future Survey (15:27)
Published: April 15, 2024 by FoodNavigator-USA.com
Novavax investor Shah Capital attempting to nominate two new independent board directors; Shah claims Novavax has been historically mismanaged
Published: April 15, 2024 by FiercePharma
Activist investor critical of Novavax for not using mRNA vaccination fears to boost sales of its COVID-19 vaccine; Shah Capital wants Novavax to market its protein-based vaccine directly to people concerned about safety of mRNA vaccines
Published: April 15, 2024 by Quartz

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count